The biology of pulmonary aspergillus infections

Adilia Warris1

  • 1University of Aberdeen, School of Medicine and Dentistry, Division of Applied Medicine, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.

The Journal of Infection
|August 20, 2014
PubMed

Insights

Pulmonary aspergillus infections, caused by Aspergillus fumigatus, range from saprophytic to invasive forms. Understanding the host-fungus interaction is crucial for managing these diverse lung diseases.

Area of Science:

  • Mycology
  • Pulmonology
  • Immunology

Background:

  • Pulmonary aspergillus infections are primarily caused by Aspergillus fumigatus.
  • These infections manifest as saprophytic, allergic, or invasive diseases.
  • Invasive pulmonary aspergillosis is a severe condition in immunocompromised individuals with high mortality.

Purpose of the Study:

  • To classify pulmonary aspergillus infections based on clinical syndromes.
  • To differentiate histopathological presentations into angio-invasive and airway-invasive disease.
  • To highlight the need for further research into host-Aspergillus interactions for improved clinical management.

Main Methods:

  • Clinical syndrome classification.
  • Histopathological differentiation (angio-invasive vs. airway-invasive).

Main Results:

  • Aspergillus infections present as saprophytic (in lung cavities), allergic (e.g., allergic bronchopulmonary aspergillosis in cystic fibrosis, severe asthma), or invasive (in immunocompromised patients).
  • Disease severity correlates with host immune response: either insufficient defense or exaggerated inflammation.
  • Both extremes of host response lead to overt disease with distinct clinical signs.

Conclusions:

  • Pulmonary aspergillosis encompasses a spectrum of diseases influenced by host immunity.
  • Effective management requires a deeper understanding of the specific host-Aspergillus interactions.
  • Further research is essential to improve therapeutic strategies for all forms of pulmonary aspergillosis.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
2.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
20